Great success of ABIVAX IPO on Euronext Paris, with €57.7 million raised
Great success of ABIVAX IPO on Euronext Paris, with €57.7 million raised
June 23, 2015
- Full exercise of the extension clause and of the overallotment option
- Share price set at €21.30 - mid-point of the price range
- Market capitalization of €205 million on a non-diluted basis